This article walks through what the before and after timeline actually looks like at 3, 6, and 12 months based on clinical observations from our patient population, what affects the magnitude of results, and who is the right candidate for this protocol
Alternatives to GLP-1 Drugs GLP-1 agonists are not the only option for weight loss
If you miss a dose, skip it and resume your usual schedule the next day
What Is the Sermorelin & Ipamorelin Blend
is supported by NIH research grants R01MD014712, U2CDK114886, UL1TR002319, U54DK083912, U01DK100846, OT2HL161847, UM1AI109568, OT2OD032581 and CDC project numbers 75D301-21-P-12254 and 75D301-23-C-18264